Safety and outcomes of maintenance therapy with third-generation tyrosine kinase inhibitor after allogeneic hematopoietic cell transplantation in Philadelphia chromosome positive acute lymphoblastic leukemia patients with T315I mutation

Huan Chen, Lan‐Ping Xu, Xiaohui Zhang, Yu Wang, Yu‐Hong Chen, Chen-Hua Yan, Cheng Yi-fei, Wei Han, Yao Chen, Ya-Zhen Qin, Yanrong Liu, Ying‐Jun Chang, Kai‐Yan Liu, Xiao‐Jun Huang